Faculty Information - Yamasaki Keishi

Yamasaki Keishi

Department / Course FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences

Job

Book and thesis
1.	2024	Papers	Possible Involvement of Protein Binding Inhibition in Changes in Dexmedetomidine Concentration in Extracorporeal Circuits during Midazolam Use. Biological & pharmaceutical bulletin 47 (2),pp.389-393 (Co-authored)
2.	2024	Papers	Development of α-Cyclodextrin-Based Orally Disintegrating Tablets for 4-Phenylbutyrate. Pharmaceutics 16,pp.82 (Co-authored)
3.	2024	Papers	Preparation and in vitro characterization of fatty-acid modified pirarubicin nanosuspensions stabilized by albumin. Chem Pharm Bull 72,pp.21-27 (Co-authored)
4.	2023	Papers	Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency. Int J Mol Sci 24,pp.15091 (Co-authored)
5.	2023	Papers	Encapsulation of an Antioxidant in Redox-Sensitive Self-Assembled Albumin Nanoparticles for the Treatment of Hepatitis. ACS Nano doi: 10.1021/acsnano.3c02877 (Co-authored)
6.	2023	Papers	Structural basis of the change in the interaction between mycophenolic acid and subdomain IIA of human serum albumin during renal failure. J Med Chem 66,pp.951-961 (Co-authored)
7.	2023	Papers	Study of the Inclusion Complexes Formed Between 4-Phenylbutyrate and α-, β-, and γ-Cyclodextrin in Solution and Evaluation on Their Taste-Masking Properties. J Pharm Pharmacol 75,pp.236-244 (Co-authored)
8.	2022	Papers	The Chlorine Atoms of Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in the Subdomain IIIA of Human Serum Albumin. ACS Omega doi.org/10.1021/acsomega.2c02929 (Co-authored)
9.	2022	Papers	An in vitro comparative study of the binding of caspofungin and micafungin to plasma proteins. J Pharm Pharmacol 74,pp.88-93 (Co-authored)
10.	2022	Papers	Novel nitric oxide donor, nitrated phenylbutyrate, induces cell death of human pancreatic cancer cells and suppress tumor growth of cancer xenografts. Oncology Reports 48,pp.178 (Co-authored)
11.	2022/03	Papers	The Nitrated Form of Nateglinide Induces Apoptosis in Human Pancreatic Cancer Cells Through a Caspase-dependent Mechanism. Anticancer research 42 (3),pp.1333-1338 (Co-authored)
12.	2022	Papers	Effect of Fatty Acids and Uremic Toxins on the binding of Nateglinide, an Insulin Secretagogue, to Site II on Human Serum Albumin Biol. Pharm. Bull. 45,pp.803-805 (Co-authored)
13.	2022	Papers	Effects of Myristate on the Induced Circular Dichroism Spectra of Aripiprazole Bound to Human Serum Albumin: A Structural–Chemical Investigation ACS OMEGA 7 (5),pp.4413-4419 (Co-authored)
14.	2022	Papers	In vitro and in vivo assessment of Atemoya fruit (Annona atemoya) for food-drug interaction. Eur J Drug Metab Pharmacokinet 47,pp.177-185 (Co-authored)
15.	2022	Papers	Trimethoxy trityl groups as a potent substituent for anti-cancer cytidine analog prodrugs. J Pharm Sci doi: 10.1016/j.xphs.2022.04.020 (Co-authored)
16.	2021	Papers	The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients toxins 13,pp.811 (Co-authored)
17.	2021	Papers	Possible role of electrolytes on the formation of precipitates during the infusion of nafamostat mesilate in hemodialysis Biol Pharm Bull 44 (2),pp.259-265 (Co-authored)
18.	2021	Papers	Interaction of benzbromarone with subdomains IIIA and IB/IIA on human serum albumin as the primary and secondary binding regions. Mol Pharm doi: 10.1021/acs.molpharmaceut.0c01004 (Co-authored)
19.	2021	Papers	Effects of Uremic Toxins on the Binding of Aripiprazole to Human Serum Albumin. Biol Pharm Bull 44 (3),pp.437-441 (Co-authored)
20.	2021	Papers	Possible roles of intestinal P-glycoprotein and cytochrome P450 3A on the limited oral absorption of irinotecan. J Pharm Pharmacol. (Co-authored)
21.	2021	Papers	Pharmacokinetics of 4'-cyano-2'-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney disease. J Infect Chemother 27,pp.702-706 (Co-authored)
22.	2021	Papers	Antipruritic and anti-herpes virus activities of bisabolol oxide A, the main constituent in the essential oil of German chamomile (Matricaria recutita L.) Cur Top Phytochem 17,pp.63-68 (Co-authored)
23.	2020	Papers	Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity. J Pharm Pharmacol doi: 10.1111/jphp.13212 (Co-authored)
24.	2020	Papers	Characterization of the interaction of daptomycin with site II on human serum albumin. Journal of pharmaceutical sciences https://doi.org/10.1016/j.xphs.2020.06.011 (Co-authored)
25.	2020	Papers	Effects of Oxidation of Human Serum Albumin on the Binding of Aripiprazole. Biol Pharm Bull 43,pp.1023-1026 (Co-authored)
26.	2020	Papers	Characterization of Bovine Lactoferrin Nanoparticle Prepared by Desolvation Technique Chem Pharm Bull (Tokyo) . 68 (8),pp.766-772 (Co-authored)
27.	2020	Papers	Hepatic cytochrome P450 profiles in hemorrhagic shock model rats after transfusion with stored red blood cells. J Pharm Sci doi: 10.1016/j.xphs.2020.08.015. (Co-authored)
28.	2020	Papers	Evaluation of cytochrome P450-based drug metabolism in hemorrhagic shock rats that were transfused with native and an artificial red blood cell preparation, Hemoglobin-vesicles. doi.org/10.1016/j.dmpk.2020.06.005 (Co-authored)
29.	2020	Papers	Assessing cytochrome P450-based drug-drug interactions with Hemoglobin-vesicles, an artificial red blood cell preparation, in healthy rats. doi.org/10.1016/j.dmpk.2020.06.005 (Co-authored)
30.	2020	Papers	A Safety Evaluation Study in Mice Revealed that Albumin Dimer is Safe for Medical and Pharmaceutical Applications BPB Reports 3 (2),pp.87-91 (Co-authored)
31.	2020	Papers	Serum Albumin, Lipid and Drug Binding,pp.383-397 (Co-authored)
32.	2020	Papers	In Vivo Evaluation of Drug Dialyzability in a Rat Model of Hemodialysis PLoS One 15 (6),pp.e0233925 (Co-authored)
33.	2019	Papers	Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique. Cancer Chemother Pharmacol. 83,pp.1113-1120 (Co-authored)
34.	2019	Papers	Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying. European journal of pharmaceutical science 139,pp.105064 (Co-authored)
35.	2019	Papers	Further Evidence Regarding the Important Role of Chlorine Atoms of Aripiprazole on Binding to the Site II Area of Human Albumin. J Pharm Sci. 108,pp.1890-1895 (Co-authored)
36.	2019	Papers	Cell uptake and anti-tumor effect of liposomes containing encapsulated paclitaxel-bound albumin against breast cancer cells in 2D and 3D cultured models. Journal of Drug Delivery Science and Technology (Co-authored)
37.	2019/07	Papers	α₁-Acid Glycoprotein Has the Potential to Serve as a Biomimetic Drug Delivery Carrier for Anti-Cancer Agents. Journal of pharmaceutical sciences (Co-authored)
38.	2019	Papers	Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer ACS Omega 4,pp.8693-8700 (Co-authored)
39.	2019/09	Papers	Interaction of Aripiprazole with Human α1-Acid Glycoprotein. Journal of pharmaceutical sciences (Co-authored)
40.	2018	Papers	Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives. Chemical & pharmaceutical bulletin 66 (4),pp.382-390 (Co-authored)
41.	2018	Papers	Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure. ACS omega 3 (10),pp.13790-13797 (Co-authored)
42.	2018/11	Papers	Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity. Drug delivery 25 (1),pp.1266-1274 (Co-authored)
43.	2018/07	Papers	Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites. Biochemistry and biophysics reports 14,pp.155-160 (Co-authored)
44.	2018/06	Papers	Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats. The Journal of pharmacy and pharmacology 70 (6),pp.723-731 (Co-authored)
45.	2018/03	Papers	Effect of endogenous substances on the binding of sodium 4-phenylbutyrate to human serum albumin. Acta Chim Pharm Indica 8,pp.124-129 (Co-authored)
46.	2018/03	Papers	Effect of endogenous substances on the binding of sodium 4-phenylbutyrate to human serum albumin. Acta Chim Pharm Indica 8,pp.124-129 (Co-authored)
47.	2018/03	Papers	Crystal structure analysis of human serum albumin complexed with sodium 4-phenylbutyrate. Biochemistry and biophysics reports 13,pp.78-82 (Co-authored)
48.	2018/01	Papers	Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core. Journal of pharmaceutical sciences 107 (1),pp.436-445 (Co-authored)
49.	2018	Papers	Pharmacokinetic properties of a novel inosine analog, 4'-cyano-2'-deoxyinosine, after oral administration in rats. PloS one 13 (6),pp.e0198636 (Co-authored)
50.	2018	Papers	In vivo drug delivery eﬃciency of albumin-encapsulated liposomes as hydrophobic drug carriers Journal of Drug Delivery Science and Technology 47,pp.62-66 (Co-authored)
51.	2018	Papers	Glutamine deprivation enhances acetyl-CoA carboxylase inhibitor-induced death of human pancreatic cancer cells. Anticancer Res 38,pp.6683-6689 (Co-authored)
52.	2017/12	Papers	Interaction of Protizinic Acid with Human Serum Albumin: Site-to-Site Displacement of Protizinic Acid by Ibuprofen Acta Chim Pharm Indica 7 (3),pp.115-123 (Co-authored)
53.	2017/09	Papers	The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders. Journal of pharmaceutical sciences 106 (9),pp.2392-2400 (Co-authored)
54.	2017/09	Papers	Species Differences in the Binding of Sodium 4-Phenylbutyrate to Serum Albumin. Journal of pharmaceutical sciences 106 (9),pp.2860-2867 (Co-authored)
55.	2017/08	Papers	Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions. Biochimica et biophysica acta. Proteins and proteomics 1865 (8),pp.979-984 (Co-authored)
56.	2017/03	Papers	Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers. Journal of functional biomaterials 8 (1) (Co-authored)
57.	2017	Papers	The Binding of Silibinin, the Main Constituent of Silymarin, to Site I on Human Serum Albumin. Biological & pharmaceutical bulletin 40 (3),pp.310-317 (Co-authored)
58.	2017	Papers	Recombinant Human Serum Albumin Containing 3 Copies of Domain I, Has Significant in Vitro Antioxidative Capacity Compared to the Wild-Type. Biological & pharmaceutical bulletin 40 (10),pp.1813-1817 (Co-authored)
59.	2017	Papers	Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. PloS one 12 (6),pp.e0180404 (Co-authored)
60.	2017	Papers	Albumin-encapsulated liposomes: A novel drug delivery carrier with hydrophobic drugs encapsulated in the inner aqueous core. J Pharm Sci S0022-3549(17)30567-1. doi: 10 (Co-authored)
61.	2016/10	Papers	Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury. PloS one 11 (10),pp.e0165557 (Co-authored)
62.	2016/07	Papers	N-acetyl-L-methionine is a superior protectant of human serum albumin against post-translational oxidation as compared to N-acetyl-L-tryptophan. Biochemistry and biophysics reports 6,pp.266-274 (Co-authored)
63.	2016/07	Papers	Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis. Journal of controlled release : official journal of the Controlled Release Society 234,pp.49-58 (Co-authored)
64.	2016/06	Papers	Tyrosine411 and Arginine410 of Human Serum Albumin Play an Important Role in the Binding of Sodium 4-Phenylbutyrate to Site II. Journal of pharmaceutical sciences 105 (6),pp.1987-1994 (Co-authored)
65.	2016/03	Papers	Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations. Journal of pharmaceutical sciences 105 (3),pp.1043-9 (Co-authored)
66.	2016	Papers	Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury. PloS one 11 (10),pp.e0165557 (Co-authored)
67.	2016	Papers	Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study. Biological & pharmaceutical bulletin 39 (6),pp.1000-6 (Co-authored)
68.	2015/10	Papers	Establishment of a model of acetaminophen-induced hepatotoxicity in different weekly-aged ICR mice. Laboratory animals 49 (4),pp.294-301 (Co-authored)
69.	2015/08	Papers	Potential Use of Biological Proteins for Liver Failure Therapy. Pharmaceutics 7 (3),pp.255-74 (Co-authored)
70.	2015/02	Papers	Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs. The Journal of pharmacy and pharmacology 67 (2),pp.255-63 (Co-authored)
71.	2015	Papers	Interactions of Linezolid with Two Major Serum Proteins, Human Serum Albumin and Alpha-1 Acid Glycoprotein. J Pharmacol Clin Toxicol 3,pp.1045 (Co-authored)
72.	2015	Papers	Biological Responsiveness and Metabolic Performance of Liposome-Encapsulated Hemoglobin (Hemoglobin-Vesicles) in Apolipoprotein E-Deficient Mice after Massive Intravenous Injection. Biological & pharmaceutical bulletin 38 (10),pp.1606-16 (Co-authored)
73.	2014/09	Papers	N-acetyl-l-methionine is a superior protectant of human serum albumin against photo-oxidation and reactive oxygen species compared to N-acetyl-L-tryptophan. Biochimica et biophysica acta 1840 (9),pp.2806-12 (Co-authored)
74.	2014	Papers	Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin. PloS one 9 (2),pp.e87919 (Co-authored)
75.	2014	Papers	An evaluation of novel biological activity in a crude extract from Hemerocallis fulva L. var. sempervirens M. Hotta. Natural product research 28 (23),pp.2211-3 (Co-authored)
76.	2013/12	Papers	Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Life sciences 93 (25-26),pp.1017-22 (Co-authored)
77.	2013/12	Papers	Albumin-drug interaction and its clinical implication. Biochimica et biophysica acta 1830 (12),pp.5435-43 (Co-authored)
78.	2013/04	Papers	Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement method. Nuclear medicine and biology 40 (3),pp.366-70 (Co-authored)
79.	2011/11	Papers	Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former. International journal of pharmaceutics 420 (1),pp.34-42 (Co-authored)
80.	2011/04	Papers	Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding. IUBMB life 63 (4),pp.277-85 (Co-authored)
81.	2010/10	Papers	Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach. Journal of pharmaceutical sciences 99 (10),pp.4285-94 (Co-authored)
82.	2010/09	Papers	Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. International journal of pharmaceutics 397 (1-2),pp.1-8 (Co-authored)
83.	2010/07	Papers	Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans. Die Pharmazie 65 (7),pp.461-6 (Co-authored)
84.	2009/08	Papers	Competitive displacement of serum protein binding of radiopharmaceuticals with amino acid infusion investigated with N-isopropyl-p-123I-iodoamphetamine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 50 (8),pp.1378-83 (Co-authored)
85.	2008/02	Papers	Inhibitory effects of fruit juices on cytochrome P450 2C9 activity in vitro. Bioscience, biotechnology, and biochemistry 72 (2),pp.406-11 (Co-authored)
86.	2008/01	Papers	Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin. Drug metabolism and disposition: the biological fate of chemicals 36 (1),pp.81-6 (Co-authored)
87.	2007/02	Papers	The role of N-acetyl-methioninate as a new stabilizer for albumin products. Int J Pharm 329 (1-2),pp.19-24 (Co-authored)
88.	2007/02	Papers	Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Drug metabolism and disposition: the biological fate of chemicals 35 (2),pp.302-5 (Co-authored)
89.	2007/02	Papers	Adsorption of irinotecan onto oral adsorbent AST-120 (Kremezin) for preventing delayed diarrhea. Cancer chemotherapy and pharmacology 59 (3),pp.321-8 (Co-authored)
90.	2007	Papers	The role of N-acetyl-methioninate as a new stabilizer for albumin products. Int J Pharm 329,pp.19-24 (Co-authored)
91.	2006/04	Papers	Oxidation of Arg-410 promotes the elimination of human serum albumin. Biochimica et biophysica acta 1764 (4),pp.743-9 (Co-authored)
92.	2006/03	Papers	Transient inhibition of cyp3a in rats by star fruit juice. Drug metabolism and disposition: the biological fate of chemicals 34 (3),pp.343-5 (Co-authored)
93.	2005/12	Papers	Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites. Drug metabolism and disposition: the biological fate of chemicals 33 (12),pp.1911-9 (Co-authored)
94.	2005/05	Papers	Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug metabolism and disposition: the biological fate of chemicals 33 (5),pp.644-8 (Co-authored)
95.	2005/04	Papers	Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome. Drug metabolism and disposition: the biological fate of chemicals 33 (4),pp.596-602 (Co-authored)
96.	2005/03	Papers	Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro. Biological & pharmaceutical bulletin 28 (3),pp.549-52 (Co-authored)
97.	2004/12	Papers	Characterization of site I of human serum albumin using spectroscopic analyses: locational relations between regions Ib and Ic of site I. Journal of pharmaceutical sciences 93 (12),pp.3004-12 (Co-authored)
98.	2004/06	Papers	Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Drug metabolism and disposition: the biological fate of chemicals 32 (6),pp.581-3 (Co-authored)
99.	2003/09	Papers	Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humans. Biological & pharmaceutical bulletin 26 (9),pp.1371-3 (Co-authored)
100.	2003	Papers	Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats. Pharm Res. 20,pp.910-917 (Co-authored)
101.	2001/12	Papers	In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharmaceutical research 18 (12),pp.1775-81 (Co-authored)
102.	2001/05	Papers	Effect of oxidative stress on the structure and function of human serum albumin. Pharmaceutical research 18 (5),pp.632-9 (Co-authored)
103.	2001/04	Papers	Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharmaceutical research 18 (4),pp.520-4 (Co-authored)
104.	2000/05	Papers	Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen. AAPS PharmSciTech 1 (2),pp.E12 (Co-authored)
105.	1999/07	Papers	Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. Biochimica et biophysica acta 1432 (2),pp.313-23 (Co-authored)
106.	1996/07	Papers	Mode of interaction of loop diuretics with human serum albumin and characterization of binding site. Pharmaceutical research 13 (7),pp.1015-9 (Co-authored)
107.	1996/07	Papers	Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochimica et biophysica acta 1295 (2),pp.147-57 (Co-authored)
108.	1994/12	Papers	Characterization of region Ic in site I on human serum albumin. Microenvironmental analysis using fluorescence spectroscopy. Biological & pharmaceutical bulletin 17 (12),pp.1656-62 (Co-authored)
109.	1994/10	Papers	Interaction of benzothiadiazides with human serum albumin studied by dialysis and spectroscopic methods. Pharmaceutical research 11 (10),pp.1452-7 (Co-authored)
110.	1993/11	Papers	Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods. Biochemical pharmacology 46 (10),pp.1721-31 (Co-authored)
111.	1993/11	Papers	Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin. Biological & pharmaceutical bulletin 16 (11),pp.1169-74 (Co-authored)